These results are in favor of the therapeutic potential of cannabinoids in patients with obstructive sleep apnea. In comparison with placebo, dronabinol is associated with an index of apnea/hypopnea more low, to an improvement of subjective sleepiness, and greater overall satisfaction with treatment. Read More
The post A tablet with a cannabis derivative that is effective in sleep apnea appeared first on Dagga Magazine.